Insider trading activities (stock purchases, sales, and option exercises)
reported by insiders of Kura Oncology, Inc. (KURA)
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Kura Oncology, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Kura Oncology, Inc. since 2005.
The reporting company's ticker symbol is KURA. The reporting company's CIK number is 1422143.
The total value of stock buying since 2005 is $5,483,448.
The total value of stock sales since 2005 is $729,972.
The total value of stock option exercises since 2005 is $394,024.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2019-07-10||Gualberto Antonio (Head of Development & CMO)||Sale||18,000||21.11||379,908|
|2019-07-10||Gualberto Antonio (Head of Development & CMO)||Option Ex||18,000||6.15||110,700|
|2018-12-21||Ecor1 Capital Fund Qualified, L.p.||Buy||83,540||13.16||1,099,386|
|2018-12-19||Ecor1 Capital Fund Qualified, L.p.||Buy||51,879||13.84||718,005|
|2018-12-18||Ecor1 Capital Fund Qualified, L.p.||Buy||78,469||13.82||1,084,441|
|2018-12-17||Ecor1 Capital Fund Qualified, L.p.||Sale||26,520||13.20||350,064|
|2018-12-13||Ecor1 Capital Fund Qualified, L.p.||Buy||25,217||13.89||350,264|
|2018-12-11||Ecor1 Capital Fund Qualified, L.p.||Buy||15,321||13.91||213,099|
|2018-12-06||Ecor1 Capital Fund Qualified, L.p.||Buy||17,079||13.49||230,395|
|2018-12-04||Ecor1 Capital Fund Qualified, L.p.||Buy||54,645||13.08||714,756|
|2018-12-03||Ecor1 Capital Fund Qualified, L.p.||Buy||48,182||13.97||673,102|
|2018-11-06||Wilson Troy Edward (President and CEO)||Option Ex||26,041||4.80||124,996|
|2017-08-22||Wilson Troy Edward (President and CEO)||Option Ex||27,985||4.80||134,328|
|2017-04-21||Wilson Troy Edward (President and CEO)||Option Ex||5,000||4.80||24,000|
|2015-11-10||Malley Thomas (Director)||Buy||50,000||8.00||400,000|
Insider trading activities including stock purchases, stock sales, and option exercises of KURA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Kura Oncology, Inc. (symbol KURA, CIK number 1422143) see the Securities and Exchange Commission (SEC) website.